Cargando…

Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells

BACKGROUND: Paclitaxel (Taxol) is a microtubule-stabilizing drug used to treat several solid tumors, including ovarian, breast, non-small cell lung, and pancreatic cancers. The current treatment of ovarian cancer is chemotherapy using paclitaxel in combination with carboplatin as a frontline agent,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amaya, Celina, Luo, Shihua, Baigorri, Julio, Baucells, Rogelio, Smith, Elizabeth R., Xu, Xiang-Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408969/ https://www.ncbi.nlm.nih.gov/pubmed/34470602 http://dx.doi.org/10.1186/s12885-021-08722-7

Ejemplares similares

Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
por: Amaya, Celina, et al.
Publicado: (2022)

Low-Intensity Focused Ultrasound Targeted Microbubble Destruction Enhanced Paclitaxel Sensitivity by Decreasing Autophagy in Paclitaxel-Resistant Ovarian Cancer
por: Fan, Gonglin, et al.
Publicado: (2022)

Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
por: Smith, Elizabeth R., et al.
Publicado: (2022)

The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers
por: Goto, T, et al.
Publicado: (2008)

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
por: de Jong, Loek A. W., et al.
Publicado: (2023)

Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
por: Gamarra-Luques, Carlos D, et al.
Publicado: (2014)

Low-intensity pulsed ultrasound alleviating myelosuppression of Sprague-Dawley rats after combined treating by paclitaxel and carboplatin
por: Luo, Dong, et al.
Publicado: (2021)

CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021)

High-Intensity Focused Ultrasound Enhanced Anti-Tumor Activities of Paclitaxel in Breast Cancer in vitro and in vivo
por: Chen, Sha, et al.
Publicado: (2022)

Removal of Common Warts by High-Intensity Focused Ultrasound: An Introductory Observation
por: Bove, Torsten, et al.
Publicado: (2021)

Clinical trials and progress with paclitaxel in ovarian cancer
por: Kumar, Sanjeev, et al.
Publicado: (2010)

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.
por: Liebmann, J. E., et al.
Publicado: (1993)

Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.
por: Vukovic, V., et al.
Publicado: (1997)

Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer
por: Song, Taejong, et al.
Publicado: (2017)

In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses
por: Lee, Jeong Hoon, et al.
Publicado: (2021)

Breaking malignant nuclei as a non-mitotic mechanism of taxol/paclitaxel
por: Smith, Elizabeth R., et al.
Publicado: (2021)

Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles
por: Li, Jing, et al.
Publicado: (2019)

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2015)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
por: Affatato, Roberta, et al.
Publicado: (2022)

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
por: Tan, Xiangbin, et al.
Publicado: (2023)

Amorphous Nanosuspensions Aggregated from Paclitaxel–Hemoglobulin Complexes with Enhanced Cytotoxicity
por: Qin, Chao, et al.
Publicado: (2018)

Bioorthogonal Uncaging of Cytotoxic Paclitaxel through Pd Nanosheet–Hydrogel Frameworks
por: Pérez-López, Ana M., et al.
Publicado: (2020)

Natural compound Tan-I enhances the efficacy of Paclitaxel chemotherapy in ovarian cancer
por: Zhou, Jin, et al.
Publicado: (2020)

Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection
por: Lu, Jian-Feng, et al.
Publicado: (2012)

Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
por: Borghese, Cinzia, et al.
Publicado: (2020)

A modified McCabe score for stratification of patients after intensive care unit discharge: the Sabadell score
por: Fernandez, Rafael, et al.
Publicado: (2006)

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
por: Howell, Sacha J, et al.
Publicado: (2008)

Effectiveness of ultrasound‐guided removal of intrauterine devices
por: Townsend, Lynn, et al.
Publicado: (2022)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
por: Wang, Ning, et al.
Publicado: (2012)

Coronary Artery Thrombosis Associated With Paclitaxel in Advanced Ovarian Cancer
por: Park, Sang-Ho, et al.
Publicado: (2009)

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells
por: Liu, Zeng, et al.
Publicado: (2016)

Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells
por: Ovejero-Sánchez, María, et al.
Publicado: (2022)

Enhancing Effects of Curcumin on Cytotoxicity of Paclitaxel, Methotrexate and Vincristine in Gastric Cancer Cells
por: Ebrahimifar, Meysam, et al.
Publicado: (2017)

Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and in vitro cytotoxicity
por: Gagliardi, Agnese, et al.
Publicado: (2019)

PEGylated Paclitaxel Nanomedicine Meets 3D Confinement: Cytotoxicity and Cell Behaviors
por: Lin, Wenhai, et al.
Publicado: (2023)

Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids
por: Hossein, Ghamartaj, et al.
Publicado: (2019)

Intensive Cytotoxic Chemotherapy
por: Bagshawe, K. D.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_280c3o4qn4f2aueqhqfnmpj5c8